Meditation and Hypnosis for Chronic Depressed Mood

This study has been completed.
Sponsor:
Information provided by:
Stanford University
ClinicalTrials.gov Identifier:
NCT00226863
First received: September 12, 2005
Last updated: September 23, 2005
Last verified: September 2005
  Purpose

This study examined whether meditation or group psychotherapy including hypnosis plus education, compared to an educational control, would ameliorate long-term depressed mood.


Condition Intervention Phase
Long Term Depressed Mood
Behavioral: meditation plus education
Behavioral: group psychotherapy with hypnosis plus education
Behavioral: education
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment

Resource links provided by NLM:


Further study details as provided by Stanford University:

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • Currently meeting DSM-IV criteria for a chronic depressive disorder, with the requirement that depressive symptoms had to have lasted for at least 2 years without a remission of 2 months or more.
  • Being 18 years of age or older.
  • Being sufficiently proficient in English to be able to participate in group therapy.
  • Being able to attend weekly meetings at Stanford.

Exclusion Criteria:

  • Concurrent bipolar disorder or severe depressive disorder (this latter was determined in supervision for the SCID interviews).
  • Presence or history of psychosis.
  • A current primary diagnosis of panic disorder, generalized anxiety disorder, or PTSD.
  • A current primary diagnosis of drug or alcohol dependency or abuse (within the last 3 months).
  • Serious suicidal risk, as defined by:
  • Current suicidality, i.e., beyond simple ideation (e.g., making threats or attempts; gathering means; has a plan); OR
  • Serious prior attempts (bodily harm; gathered means; hospitalization).
  • Has a significant medical condition that could interfere with participation in meditation/yoga.
  • Current participation in psychotherapy or a meditation group.
  • Has started (or changed level or type of) prescribed antidepressant medication or St. John’s Wort in the previous 3 months.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00226863

Sponsors and Collaborators
Stanford University
Investigators
Study Director: Lisa D. Butler, Ph.D. Stanford University
Principal Investigator: David Spiegel, M.D. Stanford University
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00226863     History of Changes
Other Study ID Numbers: 1HSA698
Study First Received: September 12, 2005
Last Updated: September 23, 2005
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Depression
Behavioral Symptoms

ClinicalTrials.gov processed this record on August 20, 2014